Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shibo Jiang

Showing results (81-90 of 580) with videos related to

Pageof 58
Sort By:
AIDS (London, England)|February 27, 2009
Synergistic efficacy of combination of enfuvirtide and sifuvirtide, the first- and next-generation HIV-fusion inhibitorsChungen Pan, Hong Lu, Zhi Qi, et al.
Cell|March 19, 2021
Antivirals with common targets against highly pathogenic virusesLu Lu, Shan Su, Haitao Yang, et al.
Frontiers in Cellular and Infection Microbiology|July 26, 2022
Advancement in the Development of Therapeutics Against Zika Virus InfectionKangchen Li, Qianting Ji, Shibo Jiang, et al.
Journal of X-Ray Science and Technology|February 20, 2025
Research on meshing method for industrial CT volume data based on iterative smooth signed distance surface reconstructionShiBo Jiang, Shuo Xu, YueWen Sun, et al.
Journal of Visualized Experiments : Jove|May 19, 2011
Protocol for recombinant RBD-based SARS vaccines: protein preparation, animal vaccination and neutralization detectionLanying Du, Xiujuan Zhang, Jixiang Liu, et al.
Reviews in Medical Virology|April 11, 2016
A new role of neuraminidase (NA) in the influenza virus life cycle: implication for developing NA inhibitors with novel mechanism of actionJie Yang, Shuwen Liu, Lanying Du, et al.
Emerging Microbes & Infections|March 9, 2016
Urgent development of effective therapeutic and prophylactic agents to control the emerging threat of Middle East respiratory syndrome (MERS)Lu Lu, Shuai Xia, Tianlei Ying, et al.
Expert Review of Vaccines|March 18, 2016
Vaccines for the prevention against the threat of MERS-CoVLanying Du, Wanbo Tai, Yusen Zhou, et al.
AIDS Research and Human Retroviruses|February 17, 2010
HIV type 1 B'/C recombinant (CRF07_BC) in virologic noncontrollers elicits neutralizing antibodies against heterologous but not autologous virusesJianping Sun, Liying Ma, Shibo Jiang, et al.
Antimicrobial Agents and Chemotherapy|April 28, 2005
Combination of candidate microbicides cellulose acetate 1,2-benzenedicarboxylate and UC781 has synergistic and complementary effects against human immunodeficiency virus type 1 infectionShuwen Liu, Hong Lu, A Robert Neurath, et al.
Pageof 58

Showing results (81-90 of 580) with videos related to

Sort By:
Pageof 58
AIDS (London, England)|February 27, 2009
Synergistic efficacy of combination of enfuvirtide and sifuvirtide, the first- and next-generation HIV-fusion inhibitorsChungen Pan, Hong Lu, Zhi Qi, et al.
Cell|March 19, 2021
Antivirals with common targets against highly pathogenic virusesLu Lu, Shan Su, Haitao Yang, et al.
Frontiers in Cellular and Infection Microbiology|July 26, 2022
Advancement in the Development of Therapeutics Against Zika Virus InfectionKangchen Li, Qianting Ji, Shibo Jiang, et al.
Journal of X-Ray Science and Technology|February 20, 2025
Research on meshing method for industrial CT volume data based on iterative smooth signed distance surface reconstructionShiBo Jiang, Shuo Xu, YueWen Sun, et al.
Journal of Visualized Experiments : Jove|May 19, 2011
Protocol for recombinant RBD-based SARS vaccines: protein preparation, animal vaccination and neutralization detectionLanying Du, Xiujuan Zhang, Jixiang Liu, et al.
Reviews in Medical Virology|April 11, 2016
A new role of neuraminidase (NA) in the influenza virus life cycle: implication for developing NA inhibitors with novel mechanism of actionJie Yang, Shuwen Liu, Lanying Du, et al.
Emerging Microbes & Infections|March 9, 2016
Urgent development of effective therapeutic and prophylactic agents to control the emerging threat of Middle East respiratory syndrome (MERS)Lu Lu, Shuai Xia, Tianlei Ying, et al.
Expert Review of Vaccines|March 18, 2016
Vaccines for the prevention against the threat of MERS-CoVLanying Du, Wanbo Tai, Yusen Zhou, et al.
AIDS Research and Human Retroviruses|February 17, 2010
HIV type 1 B'/C recombinant (CRF07_BC) in virologic noncontrollers elicits neutralizing antibodies against heterologous but not autologous virusesJianping Sun, Liying Ma, Shibo Jiang, et al.
Antimicrobial Agents and Chemotherapy|April 28, 2005
Combination of candidate microbicides cellulose acetate 1,2-benzenedicarboxylate and UC781 has synergistic and complementary effects against human immunodeficiency virus type 1 infectionShuwen Liu, Hong Lu, A Robert Neurath, et al.
Pageof 58